insulin aspart protamine and insulin aspart mix 70/30

Generic: insulin aspart

Labeler: novo nordisk pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name insulin aspart protamine and insulin aspart mix 70/30
Generic Name insulin aspart
Labeler novo nordisk pharma, inc.
Dosage Form INJECTION, SUSPENSION
Routes
SUBCUTANEOUS
Active Ingredients

insulin aspart 100 [iU]/mL

Manufacturer
Novo Nordisk Pharma, Inc.

Identifiers & Regulatory

Product NDC 73070-203
Product ID 73070-203_ec67820c-4008-4894-b933-34b28704221d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA021172
Listing Expiration 2026-12-31
Marketing Start 2002-09-11

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73070203
Hyphenated Format 73070-203

Supplemental Identifiers

RxCUI
351297 847191
UPC
0373070200114
UNII
D933668QVX
NUI
M0011417 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name insulin aspart protamine and insulin aspart mix 70/30 (source: ndc)
Generic Name insulin aspart (source: ndc)
Application Number BLA021172 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 5 SYRINGE, PLASTIC in 1 CARTON (73070-203-15) / 3 mL in 1 SYRINGE, PLASTIC (73070-203-10)
source: ndc

Packages (1)

73070-203-15 5 SYRINGE, PLASTIC in 1 CARTON (73070-203-15) / 3 mL in 1 SYRINGE, PLASTIC (73070-203-10)

Ingredients (1)

insulin aspart (100 [iU]/mL)

Linked Drug Pages (1)

Insulin Aspart Protamine and Insulin Aspart Mix 70/30 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "ec67820c-4008-4894-b933-34b28704221d", "openfda": {"nui": ["M0011417", "N0000175453"], "upc": ["0373070200114"], "unii": ["D933668QVX"], "rxcui": ["351297", "847191"], "spl_set_id": ["fc94baa4-3606-48bc-a781-9617ab6960ef"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Novo Nordisk Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE, PLASTIC in 1 CARTON (73070-203-15)  / 3 mL in 1 SYRINGE, PLASTIC (73070-203-10)", "package_ndc": "73070-203-15", "marketing_start_date": "20190910"}], "brand_name": "Insulin Aspart Protamine and Insulin Aspart Mix 70/30", "product_id": "73070-203_ec67820c-4008-4894-b933-34b28704221d", "dosage_form": "INJECTION, SUSPENSION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "73070-203", "generic_name": "insulin aspart", "labeler_name": "Novo Nordisk Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Insulin Aspart Protamine and Insulin Aspart", "brand_name_suffix": "Mix 70/30", "active_ingredients": [{"name": "INSULIN ASPART", "strength": "100 [iU]/mL"}], "application_number": "BLA021172", "marketing_category": "BLA", "marketing_start_date": "20020911", "listing_expiration_date": "20261231"}